ReviewRSC advances2023
Organic and inorganic nanomaterials: fabrication, properties and applications.
Review in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed.
- Nanoparticles for antiviral nucleotide analogs: approaches and analytical challenges.Journal of virology · 2026Review
- Nanomaterial Platforms for Endometriosis: A Systematic Review.Current medical science · 2026Review
- Engineering host‑defense peptides enhanced by artificial intelligence and nano delivery systems to overcome biofilms and antimicrobial resistance.Engineering microbiology · 2026Review
- Dynamic covalent polymer films formed by structural metamorphosis at nanoparticle surfaces.Polymer chemistry · 2026Article
- RNA-Loaded Nanoparticles for Targeted Lung Delivery.Biomedicines · 2026Review
- Silver Nanoparticles and Neurotoxicity: Mechanistic Insights and Recent Experimental Evidence.Pharmaceutics · 2026Review
- Evaluation of the Dual Impact of Nanotechnologies on Health and Environment Through Alternative Bridging Models.Advanced healthcare materials · 2026Review
- Green synthesis of ZnO nanoparticles using Citrus sinensis peel: optimizing volume ratios for enhanced antibacterial and banana preservation activities.BMC biotechnology · 2026Article
- Ecofriendly synthesis of silver nanoparticles using Barleria gibsonii and evaluation of antibacterial antioxidant cytotoxic and catalytic activities.Scientific reports · 2026Article
- Nanotherapeutic potential in glaucoma associated ocular cancers.Discover oncology · 2026Review
- Harnessing nanomedicine to target NF-κB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.Cell communication and signaling : CCS · 2026Review
- Biosynthesis, Characterization, Antibacterial and Anti-Biofilm Activity of CuO Nanoparticles using Ephedra major Plant Extract againstRecent patents on biotechnology · 2026Article
- Breaking Through Barriers: The Transformative Potential of Nanomedicine in Overcoming Drug Delivery Challenges for Psychiatric Disorders.CNS & neurological disorders drug targets · 2026Review
- Nanoparticle Carriers for Drug Delivery: An Updated Review.Pharmaceutical nanotechnology · 2026Review
- In Situ Development of Quercetin-Enhanced Layered Double Hydroxides for Targeted Osteosarcoma Therapy.ACS biomaterials science & engineering · 2025Article
- Brick by Brick the Wall Is Being Built: Particle-Based Scaffolds for Regenerative Medicine.Polymers · 2025Review
- Alginate coated mesoporous silica nanoparticles as oral delivery carrier of curcumin and quercetin to colon cancer: preparation, optimization, characterization, and anticancer activity.Drug delivery and translational research · 2025Article
- Nanomaterials and nanotechnology in otolaryngology: a narrative review.Nanomedicine (London, England) · 2025Review
- Paradoxical Features Empower Biogenic Silver Nanoparticles.Molecules (Basel, Switzerland) · 2025Review
- Impact of oil phase composition on the efficacy of nanoemulsions for verteporfin-mediated photodynamic therapy in ovarian cancer.Nanoscale advances · 2025Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanomaterials and nanoparticles are a burgeoning field of research and a rapidly expanding technology sector in a wide variety of application domains. Nanomaterials have made exponential progress due to their numerous uses in a variety of fields, particularly the advancement of engineering technology. Nanoparticles are divided into various groups based on the size, shape, and structural morphology of their bodies. The 21st century's defining feature of nanoparticles is their application in the design and production of semiconductor devices made of metals, metal oxides, carbon allotropes, and chalcogenides. For the researchers, these materials then opened a new door to a variety of applications, including energy storage, catalysis, and biosensors, as well as devices for conversion and medicinal uses. For chemical and thermal applications, ZnO is one of the most stable n-type semiconducting materials available. It is utilised in a wide range of products, from luminous materials to batteries, supercapacitors, solar cells to biomedical photocatalysis sensors, and it may be found in a number of forms, including pellets, nanoparticles, bulk crystals, and thin films. The distinctive physiochemical characteristics of semiconducting metal oxides are particularly responsible for this. ZnO nanostructures differ depending on the synthesis conditions, growth method, growth process, and substrate type. A number of distinct growth strategies for ZnO nanostructures, including chemical, physical, and biological methods, have been recorded. These nanostructures may be synthesized very simply at very low temperatures. This review focuses on and summarizes recent achievements in fabricating semiconductor devices based on nanostructured materials as 2D materials as well as rapidly developing hybrid structures. Apart from this, challenges and promising prospects in this research field are also discussed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.